2024-11-20 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

This report analyzes Intuitive Surgical Inc. (ISRG), a company that manufactures and sells da Vinci surgical systems and related instruments and accessories for minimally invasive surgery.


**1. Performance Comparison & Divergence:**

ISRG has significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for ISRG is 334.1%, while VOO's is 125.6%. This represents a difference of 208.5%, placing it at the 100th percentile of the historical relative divergence range (max: 208.5, min: -10.27).  This indicates substantial outperformance relative to the broader market.  The provided CAGR data further underscores this consistent outperformance across different timeframes, with consistently high CAGRs exceeding 100% in several periods.  However, it is important to note that past performance is not indicative of future results.


**2. Recent Price Movement:**

* **Closing Price:** 538.82
* **5-day Moving Average:** 534.51
* **20-day Moving Average:** 521.54
* **60-day Moving Average:** 498.21

The price is currently above all three moving averages, suggesting a short-term uptrend.


**3. Technical Indicators & Expected Return:**

* **RSI:** 68.57 (Approaching overbought territory, suggesting potential near-term price correction)
* **PPO:** 0.08 (Positive, indicating bullish momentum)
* **Relative Divergence (20-day):** 1.18 (+), indicating short-term upward momentum.
* **Expected Return (Long-term):** 2.29%  This represents the expected excess return over the S&P 500 for long-term (2+ years) investments.

The closing price of 538.63 is near the closing price of 538.82, indicating no significant recent sudden jumps or drops.


**4. Recent Financial Performance & Outlook:**

The provided financial data shows generally increasing revenue and EPS over the past few quarters.  While the most recent earnings data (2024-10-18) is available, there's no explicit mention of whether it met or exceeded expectations.  A comparison with analyst estimates is crucial for a complete evaluation.  Further analysis of revenue growth rate and profit margin trends would be necessary for a robust assessment of the company's financial health and future outlook.


**5.  Quarter Financial Data Analysis:**

* **Revenue and Profitability:**  Revenue shows steady growth, although the growth rate appears to have slowed slightly in the most recent quarters. Profit margins are consistently high, ranging from 65% to 68%, indicating excellent profitability.

* **Capital and Profitability:**  Equity is increasing, though ROE fluctuates, suggesting some variability in profitability.  A deeper dive into the factors driving these ROE fluctuations is needed.


**6. News and Recent Issues:**

*(This section requires access to recent news sources such as Shacknews and FINBOLD to provide current information on earnings announcements, analyst opinions, and market outlook.  Please provide relevant news articles for a complete analysis.)*  A search for recent news articles will fill this section.  The information needed to cover this would include things like earnings calls transcriptions, recent analyst rating changes, any significant regulatory updates, or any major announcements from the company.


**7. Overall Analysis:**

ISRG has demonstrated strong historical performance, significantly outperforming the S&P 500.  Recent price action suggests a short-term uptrend, supported by positive PPO and relative divergence indicators. However, the RSI is approaching overbought territory, suggesting potential near-term correction.  Long-term prospects appear positive based on the high profit margins and consistent revenue growth, provided that this trend continues. However, a more thorough analysis is needed to assess the sustainability of the current growth trajectory.  Further investigation into the most recent earnings report, along with current analyst opinions and market sentiment, is essential for a comprehensive investment decision.

**8.  Disclaimer:**  This report is for informational purposes only and does not constitute financial advice.  Investment decisions should be based on thorough research and consideration of your individual risk tolerance.
